Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Home > Press > Financing Innovation in Our New World: Utilizing Non-Dilutive Funding for Capital Efficiency

Financing Innovation in Our New World: Utilizing Non-Dilutive Funding for Capital Efficiency

San Diego, CA | Posted on May 20th, 2010

The year 2009 was rough for the capital markets, and while some believe that the worst is over, it has become clear that we must rethink the way that we finance new ventures. While many investors have moved away from very early stage investments in order to minimize risk, others argue that these times are indeed the best to start new companies.

How can we best support these companies to minimize their risk? This webinar, presented by Dr. Linda K. Molnar, Founder LKM Strategic Consulting, LLC will discuss how non-dilutive funding can be utilized alongside private or venture investments and corporate partnerships as a source of capital for early stage ventures creating a new capital efficient model. Within this context, nanotechnology-based applications, in such areas as personalized medicine and clean technology, remain at the forefront of both government funding sources and venture capital.

For registration go to

WHO: Entrepreneurs, research scientists, business professionals, technology experts

WHAT: Learn about financing strategies that work today and improve your capital efficiency.

WHERE: Online webinar; Register here

WHEN: Wednesday, May 26, 2010
11:00a.m. - 12:00 p.m. PDT


About NanoTecNexus
NanoTecNexus is a leading national industry organization with premier business services and educational programs designed to support academic research institutes and companies in the nanotech space.

For more information, please click here

Principal Contact
Adriana Vela


Copyright © NanoTecNexus

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Bioengineered nanoparticles show promise for fibrinogen manufacture, says Journal of Pharmaceutical Analysis study: Scientists engineer a nanoparticle polymer that can selectively bind to fibrinogen in human plasma, presenting a pathway for improved drug development January 14th, 2022

Photon recycling The key to high-efficiency perovskite solar cells January 14th, 2022

NSF funds Rice effort to measure, preserve quantum entanglement: Physicist Guido Pagano wins CAREER Award to develop tools for quantum computing January 14th, 2022

Tuning the bonds of paired quantum particles to create dissipationless flow: A tunable platform made from atomically thin materials may help researchers figure out how to create a robust quantum condensate that can flow without losing energy January 14th, 2022


Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021


Nanostructures get complex with electron equivalents: Nanoparticles of two different sizes break away from symmetrical designs January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

The free-energy principle explains the brain January 14th, 2022


Invited CEA-Leti Paper at IEDM 2021 Identifies Main Challenges Facing Large-Scale Si Quantum Computing: Second Paper Details Innovative Silicon Quantum Device Integration For Effective Qubit Control December 17th, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences September 1st, 2021

UVA Engineering researchers join quest to demonstrate photonic systems-on-chip: Future applications include faster, more efficient data centers and next-generation millimeter-wave wireless communication July 30th, 2021

Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress June 25th, 2021

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project